Birth of babies before the gestational age, i.e. 37 weeks, is known as preterm birth. Preterm birth is categorized into extremely preterm (less than 28 weeks), very preterm birth (28 weeks to 31 weeks), and moderate to late preterm birth (31 weeks to 36 weeks) of gestational period. Preterm birth is the biggest problem and is primarily responsible for neonatal morbidity and mortality in the U.S. According to a 2017 report by the World Health Organization (WHO), every year, 15 million babies are born prematurely across the world and it is the most common cause of death in newborn babies. There was dramatic difference in survival of premature babies depending on where they are born. For instance, in 2017, more than 90% of extremely premature babies born in low income countries died within first few days of life, while less than 10% of extremely premature babies died in high income countries. .

Tocolytic agents are also known as anti-contraction or labor suppressant drugs. Tocolytic agents inhibit uterine contraction such as beta sympathomimetic act by relaxing and smoothing muscles contraction, calcium-channels blockers antagonize calcium within myometrial cell to reduce its contractility, magnesium sulfate displaces calcium ions prevent uterine activity, and prostaglandin synthetase inhibitor impede the release of oxytocin from the posterior pituitary gland. 

The global tocolytic drugs market is driven by increase in mortality of premature babies. According to the WHO, each year, approximately 1 million babies die due to complications caused by preterm birth, multiple pregnancies, infections during pregnancy, and rise in prevalence of chronic condition such as diabetes, high blood pressure during pregnancy. However, precautionary care during birth and postnatal period, provision for antenatal steroid injections, and new techniques such as kangaroo mother care in high income countries are likely to hinder the market.

The global tocolytic drugs market can be categorized based on drug class, routes of drug administration, distribution channel, and region. In terms of drug class, the global tocolytic drugs market can be categorized into beta-sympathomimetic, calcium channel antagonist, magnesium sulphate, prostaglandin synthetase inhibitor, and others. Calcium channel antagonist is the most preferred agent due to its efficacy, fetomaternal safety, and availability. Based on route of administration, the global tocolytic drugs market can be segmented into oral, intravenous, and others. Based on distribution channels, the global market can be segmented into online pharmacies, retail pharmacies, and hospital pharmacies.

Geographically, the global tocolytic drugs market can be divided into North America, Europe, Latin America, Asia Pacific and Middle East & Africa. North America is expected to hold the largest share of the global market from 2017 to 2025 due to the higher per capita income. According to a WHO report 2017, in lower-income countries, on average, 12% of babies born too early compared with 9% in higher income countries. Europe is expected to be the second largest market due to continuous increase in research & development activities in the region. The tocolytic drugs market in Asia Pacific and Middle East & Africa is expanding at a rapid pace during the forecast period due to increase in the number of preterm births. For instance according to WHO report 2017, more than 60% of preterm births occur in Africa and Asia.

Key players operating in the global tocolytic drugs market include AstraZeneca, Bayer AG, Alkermes, Pfizer Inc., Medpharma Pharma & Chem Ind’s (L.L.C.), Solvay, Medisol Life Science Pvt. Ltd., Merit Pharmaceutical, Sandoz, Inc. (Novartis AG).

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Tocolytic Drugs Market

Pre Book